117 related articles for article (PubMed ID: 20442197)
1. Design issues in cancer screening trials.
Moss S
Stat Methods Med Res; 2010 Oct; 19(5):451-61. PubMed ID: 20442197
[TBL] [Abstract][Full Text] [Related]
2. Randomized clinical trials for cancer screening: rationale and design considerations for imaging tests.
Black WC
J Clin Oncol; 2006 Jul; 24(20):3252-60. PubMed ID: 16829649
[TBL] [Abstract][Full Text] [Related]
3. Design and analysis issues for economic analysis alongside clinical trials.
Marshall DA; Hux M
Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012
[TBL] [Abstract][Full Text] [Related]
4. Planning a cluster randomized controlled trial: methodological issues.
Christie J; O'Halloran P; Stevenson M
Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
[TBL] [Abstract][Full Text] [Related]
5. How many do I need? Basic principles of sample size estimation.
Devane D; Begley CM; Clarke M
J Adv Nurs; 2004 Aug; 47(3):297-302. PubMed ID: 15238124
[TBL] [Abstract][Full Text] [Related]
6. Estimating sample size for a randomized clinical trial of lung cancer screening.
Obuchowski NA
Contemp Clin Trials; 2008 Jul; 29(4):466-77. PubMed ID: 18088564
[TBL] [Abstract][Full Text] [Related]
7. Who's really hypertensive?--Quality control issues in the assessment of blood pressure for randomized trials.
Reid CM; Ryan P; Miles H; Willson K; Beilin LJ; Brown MA; Jennings GL; Johnston CI; Macdonald GJ; Marley JE; McNeil JJ; Morgan TO; West MJ; Wing LM
Blood Press; 2005; 14(3):133-8. PubMed ID: 16036492
[TBL] [Abstract][Full Text] [Related]
8. Taishotoyama Symposium Barriers to colorectal cancer screening: economics, capacity and adherence.
Inadomi JM
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S198-204. PubMed ID: 19120898
[TBL] [Abstract][Full Text] [Related]
9. Cluster randomized controlled trials in primary care: an introduction.
Murphy AW; Esterman A; Pilotto LS
Eur J Gen Pract; 2006; 12(2):70-3. PubMed ID: 16945880
[TBL] [Abstract][Full Text] [Related]
10. Issues in the meta-analysis of cluster randomized trials.
Donner A; Klar N
Stat Med; 2002 Oct; 21(19):2971-80. PubMed ID: 12325113
[TBL] [Abstract][Full Text] [Related]
11. Numerous violations of federal informed consent requirements.
Maloney DM
Hum Res Rep; 2004 Jan; 19(1):1-3. PubMed ID: 14997901
[No Abstract] [Full Text] [Related]
12. Promoting cancer screening among the first-degree relatives of breast and colorectal cancer patients: the design of two randomized trials.
Marcus AC; Ahnen D; Cutter G; Calonge N; Russell S; Sedlacek SM; Wood M; Manchester D; Fox L; McCaskill-Stevens W; Fairclough D; Hines S; Wenzel L; Osborn K
Prev Med; 1999 Mar; 28(3):229-42. PubMed ID: 10072740
[TBL] [Abstract][Full Text] [Related]
13. Statistical considerations in cancer screening programs.
Prorok PC; Connor RJ; Baker SG
Urol Clin North Am; 1990 Nov; 17(4):699-708. PubMed ID: 2120836
[TBL] [Abstract][Full Text] [Related]
14. ['Informed consent' and prerandomization].
de Craen AJ
Ned Tijdschr Geneeskd; 2000 Jul; 144(27):1301-3. PubMed ID: 10918907
[TBL] [Abstract][Full Text] [Related]
15. Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report.
Ferrucci L; Guralnik JM; Studenski S; Fried LP; Cutler GB; Walston JD;
J Am Geriatr Soc; 2004 Apr; 52(4):625-34. PubMed ID: 15066083
[TBL] [Abstract][Full Text] [Related]
16. Design, operation, and interpretation of clinical trials.
Pihlstrom BL; Barnett ML
J Dent Res; 2010 Aug; 89(8):759-72. PubMed ID: 20581353
[TBL] [Abstract][Full Text] [Related]
17. Randomised controlled trials in overweight children: practicalities and realities.
Warren JM; Golley RK; Collins CE; Okely AD; Jones RA; Morgan PJ; Perry RA; Baur LA; Steele JR; Magarey AM
Int J Pediatr Obes; 2007; 2(2):73-85. PubMed ID: 17763014
[TBL] [Abstract][Full Text] [Related]
18. Cancer screening: the importance of outcome measures.
Alibhai SM
Crit Rev Oncol Hematol; 2006 Mar; 57(3):215-24. PubMed ID: 16371251
[TBL] [Abstract][Full Text] [Related]
19. Historical trends in the timing of informed consent for research into intrapartum complications.
Patel D; Nasir S; Elati A; Vernon G; Weeks AD
BJOG; 2012 Feb; 119(3):361-5. PubMed ID: 22168822
[TBL] [Abstract][Full Text] [Related]
20. Some issues in screening for breast and other cancers.
Duffy SW; McCann J; Godward S; Gabe R; Warwick J
J Med Screen; 2006; 13 Suppl 1():S28-34. PubMed ID: 17227639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
